2026 ICD-10-CM Diagnosis Code E75.27Pelizaeus-Merzbacher disease
ICD-10-CM Codes›E00–E89›E70-E88›E75
- Billable — Valid for Submission
- Chronic Condition
E75.27 is a billable ICD-10-CM diagnosis code for Pelizaeus-Merzbacher disease. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Other nervous system disorders (often hereditary or degenerative) and Other specified and unspecified nutritional and metabolic disorders.
Code Identity
Code Classification
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
- Aplasia - See Also: Agenesis;
- Pelizaeus-Merzbacher - E75.27
- Merzbacher-Pelizaeus disease - E75.27
- Pelizaeus-Merzbacher disease - E75.27
External Cause of Injuries IndexGuidance
References for this code in the External Cause of Injuries Index.
- Aplasia
- Pelizaeus-Merzbacher
- Merzbacher-Pelizaeus disease
- Pelizaeus-Merzbacher disease
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Clinical InformationClinical
Other Sphingolipidosis|Other sphingolipidosis
evidence of other sphingolipidosis not specified elsewhere.Sphingolipidosis
an inherited metabolic disorder that affects the metabolism of the spinhgolipids. representative examples include gaucher disease, tay-sachs disease, and niemann-pick disease.
Code History & ChangesHistory
Replacement E75.27 replaces the following previously assigned code(s):
- E75.29 - Other sphingolipidosis
Questions About E75.27Overview
Is E75.27 (Other sphingolipidosis) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report Pelizaeus-Merzbacher disease on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
Footnotes
[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:
- The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
- The condition places limitations on self-care, independent living, and social interactions.
